首页> 美国卫生研究院文献>Pharmaceutics >Nanoemulsion as a Platform for Iontophoretic Delivery of Lipophilic Drugs in Skin Tumors
【2h】

Nanoemulsion as a Platform for Iontophoretic Delivery of Lipophilic Drugs in Skin Tumors

机译:纳米乳液作为亲肤药物在皮肤肿瘤中离子电渗的平台。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lipophilic drugs do not usually benefit from iontophoresis mainly because they do not solubilize in aqueous formulations suitable for the application of electric current. To explore the influence of iontophoresis on penetration of these drugs, a cationic nanoemulsion was developed to solubilize zinc phthalocyanine (ZnPc), a promising drug for the treatment of skin cancer. To verify the influence of particle size on iontophoresis, an emulsion of nanoemulsion-like composition was also developed. The formulations were characterized and cutaneous and tumor penetration studies were performed in vitro and in vivo, respectively. With particles of about 200 nm, the nanoemulsion solubilized 2.5-fold more ZnPc than the 13-µm emulsion. At the same concentration of ZnPc, in vitro passive penetration studies showed that the nanoemulsion increased, after 1 h of treatment, by almost 4 times the penetration of ZnPc into the viable layers of the skin when compared to the emulsion, whereas iontophoresis of nanoemulsion resulted in a 16-fold increase in ZnPc penetration in only 30 min. An in vivo study in a murine model of melanoma showed that ZnPc reached the tumor after iontophoresis of the nanoemulsion. Therefore, iontophoresis of nanoemulsions appears to be a promising strategy for the topical treatment of tumors with lipophilic drugs.
机译:亲脂性药物通常不能从离子电渗疗法中获益,主要是因为它们不溶于适合于施加电流的水性制剂。为了探索离子电渗疗法对这些药物渗透的影响,开发了一种阳离子纳米乳剂以溶解锌酞菁锌(ZnPc),这是一种有望用于治疗皮肤癌的药物。为了验证粒径对离子电渗疗法的影响,还开发了一种纳米乳液状组合物的乳液。对该制剂进行表征,并分别在体外和体内进行皮肤和肿瘤渗透研究。纳米乳液的粒径约为200 nm,其溶解的ZnPc比13 µm乳液多2.5倍。在相同的ZnPc浓度下,体外被动渗透研究表明,与乳液相比,纳米乳液在处理1小时后的渗透率几乎是ZnPc渗透到皮肤存活层的4倍,而纳米乳液的离子电渗疗法导致了仅30分钟内,ZnPc渗透率就增加了16倍。在黑色素瘤小鼠模型中进行的一项体内研究表明,ZnPc在纳米乳剂的离子电渗疗法后到达了肿瘤。因此,纳米乳的离子电渗疗法似乎是用亲脂性药物局部治疗肿瘤的有前途的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号